SlowBull
The Business Brief THURSDAY, 27 AUGUST 2026
← All stories
Markets

AstraZeneca’s Tezspire meets phase III trial goals for rare disease

1 source ·2 articles ·1h ago

Covered by 1 outlet

Investing 2

All coverage · 2 articles

Investing.com UK ·1h ago

AstraZeneca’s Tezspire meets trial goals for esophagitis

Investing.com Canada ·2h ago

AstraZeneca’s Tezspire meets phase III trial goals for rare disease